Neutrophil gelatinase-associated lipocalin increases HLA-G(+)/FoxP3(+) T-regulatory cell population in an in vitro model of PBMC.
Neutrophil gelatinase-associated lipocalin (NGAL) is emerging as a mediator of various biological and pathological states. However, the specific biological role of this molecule remains unclear, as it serves as a biomarker for many conditions. The high sensitivity of NGAL as a biomarker coupled with...
Main Authors: | Gaetano La Manna, Giulia Ghinatti, Pier Luigi Tazzari, Francesco Alviano, Francesca Ricci, Irene Capelli, Vania Cuna, Paola Todeschini, Eugenio Brunocilla, Pasqualepaolo Pagliaro, Laura Bonsi, Sergio Stefoni |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3937322?pdf=render |
Similar Items
-
Urinary neutrophil gelatinase-associated lipocalin is a biomarker of delayed graft function after kidney transplantation
by: Capelli I, et al.
Published: (2017-01-01) -
Serum neutrophil gelatinase-associated lipocalin in obese adolescents
by: Wafaa A. Kandeel, et al.
Published: (2018-09-01) -
Urinary Neutrophil Gelatinase-Associated Lipocalin Levels in Neonates
by: Chi-Nien Chen, et al.
Published: (2016-06-01) -
The origin of plasma neutrophil gelatinase-associated lipocalin in cardiac surgery
by: Arie Passov, et al.
Published: (2019-05-01) -
Urinary Excretion of Neutrophil Gelatinase-Associated Lipocalin in Diabetic Rats
by: Abraham Said Arellano-Buendía, et al.
Published: (2014-01-01)